Treeline Biosciences Secures Record $421 Million Funding for Drug Discovery

Treeline Biosciences's fundraising round sets new October record with $421 million for pharmaceutical research and development.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here